Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial, page-13

Do investors appreciate this is a Phase 2a clinical trial?  IHL’s unique IHL-42X formula is building on existing science.  One study I read reported a 30% reduction in the apnea-hypopnea index using Dronabinol versus the placebo.

Or to put it another way, the existing studies have already demonstrated efficacy in the treatment of OSA using Dronabinol. The difference is no one has completed a study in Australia and historically the use of medicinal cannabis was not a legal pharmaceutical option.

The successful psoriasis study by Botanix resulted in their share price going to $200 million and that was only a Phase 1b trial,this is Phase 2a.